Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
NCT00697749
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
230
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
HBV-MPL vaccine 208129
BIOLOGICAL:
Engerix™-B
Sponsor
GlaxoSmithKline